← Leaderboards
Azeddine Atfi
Harvard Medical School
$8,523,232
Attributed
$8,523,232
Total exposure
8
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2010–25$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,523,232 · 8
By mechanism
R01$7,556,918 · 5
T32$612,797 · 1
P30$353,517 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsGeneticInnovationMalignant NeoplasmsMediatingDesignIn VivoDrug DiscoveryCessation Of LifeDrug ToxicityMouse ModelProgramsResistance DevelopmentCancer PatientSignal PathwayAffectReportingCancer CachexiaSyndromeClinically RelevantSignal TransductionDiagnosisPrognostic MarkerCombat
Grant awards (30)
Cancer Biology Research Program$243,488
P30 · FY2025 · CA · contact PI
Targeting cancer cachexia drivers using antibody-based approaches$211,518
R01 · FY2025 · CA · contact PI
Targeting cancer cachexia drivers using antibody-based approaches$206,134
R01 · FY2025 · CA · contact PI
Targeting cancer cachexia drivers using antibody-based approaches$411,209
R01 · FY2024 · CA · contact PI
Integrative Training Program in Cancer Biology$363,479
T32 · FY2024 · CA · contact PI
Targeting Transglutaminase 2 in cancer cachexia$320,726
R01 · FY2024 · CA · contact PI
Cancer Biology Research Program$33,186
P30 · FY2024 · CA · contact PI
Exploiting the Twist1 network in cancer cachexia$348,018
R01 · FY2023 · CA · contact PI
Targeting Transglutaminase 2 in cancer cachexia$330,854
R01 · FY2023 · CA · contact PI
Integrative Training Program in Cancer Biology$249,318
T32 · FY2023 · CA · contact PI
Cancer Biology Research Program$33,186
P30 · FY2023 · CA · contact PI
Exploiting the Twist1 network in cancer cachexia$348,018
R01 · FY2022 · CA · contact PI
Targeting Transglutaminase 2 in cancer cachexia$324,540
R01 · FY2022 · CA · contact PI
Exploiting the Twist1 network in cancer cachexia$358,185
R01 · FY2021 · CA · contact PI
Targeting the TGIF/Twist1 network in osteosarcoma$354,563
R01 · FY2021 · CA · contact PI
Targeting Transglutaminase 2 in cancer cachexia$331,164
R01 · FY2021 · CA · contact PI
Cancer Biology Program$43,657
P30 · FY2021 · CA · contact PI
Targeting the TGIF/Twist1 network in osteosarcoma$354,563
R01 · FY2020 · CA · contact PI
Targeting Transglutaminase 2 in cancer cachexia$322,144
R01 · FY2020 · CA · contact PI
Exploiting the Twist1 network in cancer cachexia$283,360
R01 · FY2020 · CA · contact PI
Exploiting the Twist1 network in cancer cachexia$359,859
R01 · FY2019 · CA · contact PI
Targeting the TGIF/Twist1 network in osteosarcoma$343,925
R01 · FY2019 · CA · contact PI
Targeting the TGIF/Twist1 network in osteosarcoma$230,000
R01 · FY2018 · CA · contact PI
Targeting the TGIF/Twist1 network in osteosarcoma$118,844
R01 · FY2018 · CA · contact PI
Targeting the TGIF/Twist1 network in osteosarcoma$348,844
R01 · FY2017 · CA · contact PI
Role of TGIF in Wnt-Induced Bone Formation$316,461
R01 · FY2014 · AR · contact PI
Role of TGIF in Wnt-Induced Bone Formation$306,774
R01 · FY2013 · AR · contact PI
Role of TGIF in Wnt-Induced Bone Formation$322,920
R01 · FY2012 · AR · contact PI
Role of TGIF in Wnt-Induced Bone Formation$322,920
R01 · FY2011 · AR · contact PI
Role of TGIF in Wnt-Induced Bone Formation$381,375
R01 · FY2010 · AR · contact PI